Posted inNews and Updates
New Nerve-Repairing Peptide Shows Promise for Spinal Injury
A new nerve-repairing peptide therapy shows promising results in clinical trials, offering hope for functional recovery in spinal cord injury patients.
Posted inNews and Updates
New Ebola Treatment Trial Targets Unchallenged Viral Strain
Researchers have launched a clinical trial testing new treatments for a challenging Ebola strain. Discover the impact on outbreak preparedness and care.
Posted inNews and Updates
AI Transforming Oncology: Surgery, Drug Design, and Trials
Discover how AI is revolutionizing oncology by enhancing surgical precision, accelerating drug discovery, and optimizing clinical trial designs for patients.
Posted inNews and Updates
Bayer Partners with UCHealth to Accelerate Drug Development
Bayer joins forces with CU Anschutz, UCHealth, and Children’s Hospital Colorado to accelerate drug development and expand access to critical clinical trials.
Posted inNews and Updates
Psilocybin Therapy Shows Lasting Efficacy in Depression Study
New Phase III trial data reveals that psilocybin therapy provides durable depression relief for six months, offering a breakthrough for treatment-resistance.
Posted inNews and Updates
US Crackdown on China Clinical Trials: Industry Impact
Increased US scrutiny of China-based clinical trials threatens to disrupt global drug development, forcing pharma firms to face rising costs and delays.
Posted inNews and Updates
FibroBiologics Hits Milestone for Diabetic Foot Ulcer Trial
FibroBiologics achieves key milestone for CYWC628, a novel diabetic foot ulcer therapy, as it prepares for an upcoming Phase 1/2 clinical trial.
Posted inNews and Updates
AI in Drug Discovery: Why Billion-Dollar Bets Are Failing
Despite $7 billion in funding, AI-driven drug discovery has yet to yield a single FDA-approved drug. Discover why the industry is shifting its strategy.
Posted inNews and Updates
Anixa Biosciences Advances Phase 1 Ovarian Cancer Trial
Anixa Biosciences has moved to the fifth cohort of its Phase 1 ovarian cancer vaccine trial, marking a key milestone in developing targeted immunotherapy.
Posted inNews and Updates
AI Agents and Real-World Data Transforming Clinical Trials
Discover how agentic AI and real-world data are revolutionizing clinical trial design to accelerate drug development and enhance patient safety protocols.